Immune Therapy for Chronic Lymphocytic Leukemia Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond

被引：7
|
作者：
Shadman, Mazyar [1 ,2 ]
Maloney, David G. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North,D5-396, Seattle, WA 98109 USA
[2] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 04期
关键词：
CLL; SLL; Allogeneic transplant; CAR-T therapy; Immunotherapy; LONG-TERM OUTCOMES; FOLLOW-UP; COMMITTEE; IBRUTINIB; SOCIETY; BEHALF; BLOOD;
D O I：
10.1016/j.hoc.2021.03.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：847 / 862
页数：16
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
    Reinhardt, Bryanna
    Lee, Patrick
    Sasine, Joshua P. P.
    CELLS, 2023, 12 (04)
  • [22] Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
    Ma, Kun
    Hu, Ping
    CANCERS, 2023, 15 (23)
  • [23] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [24] The Promise of Chimeric Antigen Receptor T-Cell Therapy
    Frey, Noelle V.
    Porter, David L.
    ONCOLOGY-NEW YORK, 2016, 30 (10): : 880 - +
  • [25] Chimeric antigen receptor T-cell therapy for glioblastoma
    Rodriguez, Analiz
    Brown, Christine
    Badie, Behnam
    TRANSLATIONAL RESEARCH, 2017, 187 : 93 - 102
  • [26] Biomarkers in chimeric antigen receptor T-cell therapy
    Kong, Weimin
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    Fraietta, Joseph A.
    BIOMARKERS IN MEDICINE, 2018, 12 (05) : 415 - 418
  • [27] Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Wilcox, Nicholas S.
    Bedoya, Felipe
    Chen, Fang
    Orlando, Elena
    Brogdon, Jennifer L.
    Hwang, Wei-Ting
    Frey, Noelle
    Young, Regina M.
    Pequignot, Edward
    Ambrose, David E.
    Levine, Bruce L.
    Bitter, Hans
    Porter, David L.
    Xu, Jun
    June, Carl H.
    Melenhorst, Jan Joseph
    BLOOD, 2016, 128 (22)
  • [28] Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis
    Shahzad, Moazzam
    Siddiqui, Raheel S.
    Abbas, Sakina
    Chaudhary, Sibgha Gull
    Ahmed, Mamoon
    Shah, Amna Y.
    Arslan, Muhammad
    Anwar, Iqra
    Balusu, Ramesh
    Bansal, Rajat
    Ahmed, Nausheen
    Shune, Leyla
    Hematti, Peiman
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    BLOOD, 2021, 138
  • [29] Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients
    Fan, Fuli
    Yoo, Hyeon Joo
    Stock, Sophia
    Wang, Lei
    Liu, Yibin
    Schubert, Maria-Luisa
    Wang, Sanmei
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Gern, Ulrike
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (02) : 419 - 428
  • [30] Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
    Frey, Noelle, V
    Shaw, Pamela A.
    Hexner, Elizabeth O.
    Pequignot, Edward
    Gill, Saar
    Luger, Selina M.
    Mangan, James K.
    Loren, Alison W.
    Perl, Alexander E.
    Maude, Shannon L.
    Grupp, Stephan A.
    Shah, Nirav N.
    Gilmore, Joan
    Lacey, Simon F.
    Melenhorst, Jos J.
    Levine, Bruce L.
    June, Carl H.
    Porter, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05) : 415 - 422
12345